US drug companies and the NHS
Listen now
Description
Is Britain's health service really up for sale? Ahead of a general election in the UK, Ed Butler looks at why the NHS probably gets a good deal on drug prices compared with other countries, and why US drug companies might want the health service on the table in any post-Brexit trade deal between the US and the UK. We hear from the BBC's health editor Hugh Pym, US pharmaceutical industry analyst Nielsen Hobbs and Professor Allyson Pollock, director of the Institute of Health and Society at Newcastle University.
(Photo: Protestors show support for the NHS at a protest in London, Credit: Getty Images)
More Episodes
It’s estimated that 90% of traded goods travel over the oceans. But for the seafarers who make that happen, it’s not always an easy process.
Thousands of incidents of corruption within the industry have been reported to the Maritime Anti-Corruption Network, who in this episode, tell Ruth...
Published 04/17/24
Published 04/17/24
As India enters election season, we look at the crucial female vote.
For decades, the number of women turning out to vote in India has been low, but that’s changed in the last decade.
Now, political parties are deliberately targeting policies at women, to try and win over this key group.
We...
Published 04/16/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
